Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 10/20 | 0.50 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | PTGDR | Q13258 | 7/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28151182 | 0.92 | HRH4 (0.52) | HRH4TLR8ALDH1A1SMN1; SMN2PTGDR | |
| SCHEMBL28043774 | 0.89 | HRH4 (0.49) | HRH4TLR8ALDH1A1SMN1; SMN2PTGDR | |
| SCHEMBL28043806 | 0.89 | ALDH1A1 (0.52) | HRH4TLR8ALDH1A1SMN1; SMN2PTGDR | |
| SCHEMBL28043771 | 0.89 | HRH4 (0.62) | HRH4TLR8ALDH1A1SMN1; SMN2PTGDR | |
| SCHEMBL28043714 | 0.88 | HRH4 (0.50) | HRH4TLR8ALDH1A1SMN1; SMN2PTGDR | |
| SCHEMBL28267214 | 0.87 | PTGDR (0.57) | PTGDR | |
| SCHEMBL28152055 | 0.86 | PTGDR (0.48) | HRH4TLR8ALDH1A1SMN1; SMN2PTGDR | |
| SCHEMBL28151132 | 0.85 | CA1 (0.56) | HRH4ALDH1A1SMN1; SMN2PTGDR | |
| SCHEMBL28152277 | 0.85 | HRH4 (0.48) | HRH4TLR8ALDH1A1SMN1; SMN2PTGDR | |
| SCHEMBL28151149 | 0.84 | HRH4 (0.64) | HRH4TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105143206-B | Pyrimidine -2,4- diamine derivative for treating cancer | 托马斯·黑勒戴药物研究基金会 | 2019-01-15 | — | — | CN | claimed |
| CN-105143206-B | Pyrimidine -2,4- diamine derivative for treating cancer | 托马斯·黑勒戴药物研究基金会 | 2019-01-15 | — | — | CN | disclosed |
| CN-106794181-A | MTH1 inhibitors for the treatment of inflammatory and autoimmune conditions | 托马斯·黑勒戴药物研究基金会 | 2017-05-31 | — | — | CN | disclosed |
| CN-105143206-A | Pyrimidine-2,4-diamine derivatives for treatment of cancer | THOMAS HELLEDAYS STIFTELSE F R MEDICINSK FORSKNING | 2015-12-09 | — | — | CN | disclosed |